Novo's Wegovy pill tracks 3,071 prescriptions in first days of launch

LONDON, Jan ⁠16 (Reuters) - ⁠Novo ‍Nordisk's Wegovy pill hit ‍3,071 U.S. prescriptions in ​the first four days ​after its launch, IQVIA data shared by analysts on ​Friday showed, as investors closely watch ​to see if the firm ‌can ram home its first-mover advantage against ​rival Eli ⁠Lilly in a competitive weight-loss ‌market.

The data reflects retail prescriptions for ‌oral Wegovy, not those filled ‌through the drugmaker's online NovoCare Pharmacy, so actual ‍prescription numbers will be higher, Barclays ⁠analysts said in a note.

(Reporting by Bhanvi Satija; Editing by Joe Bavier)

You May Also Be Interested In

• Russia gives foreign airlines clarifications on safety measures, Interfax reports
• Basketball-US prepare for toughest-ever World Cup with Wilson's sudden absence
• Belgium reports about 3,000 excess deaths over summer due to heat